Uniqure

Yahoo Finance • 12 days ago

Considering Uniqure NV (QURE) Stock? Read the AMT-130 Message

Uniqure NV (NASDAQ:QURE) is one of the best gene therapy stocks to buy in 2026. Uniqure shares have gained 60% over the past month and more than doubled over the past year. The Street believes the stock’s rally isn’t done yet and anticipat... Full story

Yahoo Finance • 27 days ago

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~ ~ Progressing AMT-130 toward expected UK regulatory submission; MAA on track for third quarter of 2026 following s... Full story

Yahoo Finance • last month

UniQure Advances Toward UK Filing For AMT-130 After Positive MHRA Pre-Submission Meeting; Stock Up

(RTTNews) - uniQure N.V. (QURE) said it has completed a successful pre-submission meeting with the UK Medicines and Healthcare products Regulatory Agency (MHRA), clearing the path for a planned Marketing Authorization Application (MAA) for... Full story

Yahoo Finance • last month

uniQure N.V. (QURE) Stock Posts 30% Growth from Last Year

uniQure N.V. (NASDAQ:QURE) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The stock registered a 32.28 percent growth in the past year and a 24.84 percent year-to-date decline.Is uniQure N.V. (QURE) the Most Promi... Full story

Yahoo Finance • 2 months ago

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure N.V. Lawsuit – QURE

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losse... Full story

Yahoo Finance • 2 months ago

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violatio... Full story

Yahoo Finance • 2 months ago

QURE FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “C... Full story

Yahoo Finance • 2 months ago

מועד אחרון לתביעה הייצוגית נגד QURE: רוזן, משרד עורכי דין מוביל, מעודד משקיעים ב-uniQure N.V עם הפסדים העולים על 100,000 דולר לקבל ייעוץ משפטי לפני המועד החשוב ב-13 באפריל בתביעה ייצוגית בניירות ערך – QURE

ניו יורק, April 09, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את המניות הרגילות של uniQure N.V. (נאסד"ק: QURE) בין התאריכים 24 בספטמבר 2025 עד 31 ב... Full story

Yahoo Finance • 2 months ago

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Who is Involved: uniQure N.V. (NasdaqGS: QURE) investors that purchased between September 24, 2025 and October 31, 2025When to Act: Deadline to file Lead Plaintiff applications is April 13, 2026Basis: uniQure shares fell on disclosure of F... Full story

Yahoo Finance • 2 months ago

UNIQURE N.V. (NASDAQ: QURE) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 13, 2026

PHILADELPHIA, April 06, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against uniQure N.V.(NASDAQ: QURE) (“uniQure” or the “Company”) on behalf of investors... Full story

Yahoo Finance • 2 months ago

UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “C... Full story

Yahoo Finance • 2 months ago

UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In uniQure (QURE) To Contact Him Directly To Discuss Their Options If you purchased or acquired uniQure ordinary shares between Septemb... Full story

Yahoo Finance • 2 months ago

QURE SHAREHOLDER ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data

SAN FRANCISCO, April 02, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is updating its investigation into uniQure N.V. (NASDAQ: QURE) a series of extraordinary rebukes by Food and Drug Administration (FDA) o... Full story

Yahoo Finance • 2 months ago

QURE INVESTOR ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data

Firm Reminds Investors of April 13 Lead Plaintiff Deadline in Pending Securities Class Action SAN FRANCISCO, March 31, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is updating its investigation into uniQur... Full story

Yahoo Finance • 2 months ago

ROSEN, A TRUSTED AND LEADING INVESTOR RIGHTS FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “C... Full story

Yahoo Finance • 2 months ago

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE

NEW ORLEANS, March 25, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against u... Full story

Yahoo Finance • 2 months ago

uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V.Investor Summary Who: uniQure N.V. (NASDAQ: QURE)What: Securities fraud class action lawsuit filedClass Period: September 24, 2025, a... Full story

Yahoo Finance • 2 months ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “C... Full story

Yahoo Finance • 2 months ago

uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline

Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V.Investor Summary Who: uniQure N.V. (NASDAQ: QURE)What: Securities fraud class action lawsuit filedClass Period: September 24, 2025, a... Full story

Yahoo Finance • 2 months ago

QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data

SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is updating its investigation into uniQure N.V. (NASDAQ: QURE) a series of extraordinary rebukes by Food and Drug Administration (FDA) o... Full story